Publication:
Toll-like recepwtor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases 1/2

dc.contributor.authorPalani C.D.
dc.contributor.authorRamanathapuram L.
dc.contributor.authorLam-Ubol A.
dc.contributor.authorKurago Z.B.
dc.date.accessioned2021-04-05T03:21:54Z
dc.date.available2021-04-05T03:21:54Z
dc.date.issued2018
dc.date.issuedBE2561
dc.description.abstractPatient treatment for oral squamous cell carcinoma (OSCC) not associated with Human papillomavirus remains problematic. OSCC microenvironment is typically inflamed and colonized by microorganisms, providing ligands for toll-like receptors (TLR). In immune cells TLR2 and TLR4 activate NF-kB and extracellular signal regulated kinase (ERK)1/2 pathways, leading to upregulation of inhibitory adenosine receptors A2a and A2b, and reduction in stimulatory A1 and A3. How TLR and adenosine receptors function in SCC cells is not understood. To address this gap, we evaluated TLR and adenosine receptor expression and function in human OSCC cells and keratinocytes. TLR2 and A2a were co-expressed in pre-cancer and SCC cells of 17 oral specimens. In vitro, 5/6 OSCC lines expressed more TLR2 than TLR1, 4 or 6 mRNA. TLR2 ligands stimulated A2a expression in TLR2-high cell lines, but no A1 or A3 was detected with or without stimuli. In TLR2-high OSCC, TLR2/1, 2/6 and adenosine receptor agonists activated ERK1/2. TLR2-mediated ERK1/2 phosphorylation resulted in accumulation of c-FOS, ERK-dependent cell proliferation and reduced caspase-3 activity. Similar ERK1/2-dependent proliferation and decreased caspase-3 activity were caused by combined TLR2 and adenosine receptor stimuli. We conclude that TLR2 and adenosine receptor agonists, known to be present in the tumor microenvironment, may contribute to OSCC progression in part via direct effects on the ERK1/2 pathway in squamous carcinoma cells. © Palani et al.
dc.format.mimetypeapplication/pdf
dc.identifier.citationOncotarget. Vol 9, No.6 (2018), p.6814-6829
dc.identifier.doi10.18632/oncotarget.23784
dc.identifier.issn19492553
dc.identifier.other2-s2.0-85040926472
dc.identifier.urihttps://hdl.handle.net/20.500.14740/3962
dc.rights.holderScopus
dc.subject.otherAdenosine A2a receptor
dc.subject.otherCaspase 3
dc.subject.otherMessenger RNA
dc.subject.otherMitogen activated protein kinase 1
dc.subject.otherMitogen activated protein kinase 3
dc.subject.otherProtein c fos
dc.subject.otherToll like receptor 1
dc.subject.otherToll like receptor 2
dc.subject.otherToll like receptor 4
dc.subject.otherToll like receptor 6
dc.subject.otherArticle
dc.subject.otherBioaccumulation
dc.subject.otherCancer growth
dc.subject.otherCell proliferation
dc.subject.otherClinical article
dc.subject.otherControlled study
dc.subject.otherEnzyme activation
dc.subject.otherEnzyme activity
dc.subject.otherEnzyme phosphorylation
dc.subject.otherHuman
dc.subject.otherHuman cell
dc.subject.otherHuman tissue
dc.subject.otherIn vitro study
dc.subject.otherKeratinocyte
dc.subject.otherMouth squamous cell carcinoma
dc.subject.otherOral squamous cell carcinoma cell line
dc.subject.otherProtein expression
dc.subject.otherProtein function
dc.subject.otherProtein induction
dc.subject.otherTLR signaling
dc.subject.otherTumor promotion
dc.titleToll-like recepwtor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases 1/2
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85040926472&doi=10.18632%2foncotarget.23784&partnerID=40&md5=aa102c790c21eb7cfd4b825115e02391

Files